In conclusion, our research successfully demonstrated that the TMEM65 is highly expressed in 24 kinds of cancers and showed a correlation with survival, immune infiltration, and recent research hotspots (pyroptosis, DNA repairing, autophagy, ferroptosis, and drug sensitivity). The gene discussed is TMEM65; the disease is cancer.